Front & Back Matter.
- Published in:
- 2018
- Publication type:
- Other
Works matching IS 22969403 AND DT 2018 AND VI 2 AND IP 4
Results: 8
1
2
Treatment of Active Crohn’s Disease with Exclusive and Partial Enteral Nutrition: A Pilot Study in Adults.
- Published in:
- Inflammatory Intestinal Diseases, 2018, v. 2, n. 4, p. 219, doi. 10.1159/000489630
- By:
- Publication type:
- Article
3
High Prevalence of Vitamin D Deficiency among Patients with Inflammatory Bowel Disease.
- Published in:
- Inflammatory Intestinal Diseases, 2018, v. 2, n. 4, p. 200, doi. 10.1159/000489010
- By:
- Publication type:
- Article
4
The Management of Inflammatory Bowel Disease in Elderly: Current Evidence and Future Perspectives.
- Published in:
- Inflammatory Intestinal Diseases, 2018, v. 2, n. 4, p. 189, doi. 10.1159/000490053
- By:
- Publication type:
- Article
5
Eribulin Does Not Prevent Epithelial-to-Mesenchymal Transition in HT-29 Intestinal Epithelial Cells.
- Published in:
- Inflammatory Intestinal Diseases, 2018, v. 2, n. 4, p. 211, doi. 10.1159/000490052
- By:
- Publication type:
- Article
6
Contents.
- Published in:
- Inflammatory Intestinal Diseases, 2018, v. 2, n. 4, p. I, doi. 10.1159/000492047
- Publication type:
- Article
7
Efficacy and Safety of Dose Escalation to Adalimumab 80 mg Every Other Week in Japanese Patients with Crohn’s Disease Who Lost Response to Maintenance Therapy.
- Published in:
- Inflammatory Intestinal Diseases, 2018, v. 2, n. 4, p. 228, doi. 10.1159/000486786
- By:
- Publication type:
- Article
8
Erratum.
- Published in:
- Inflammatory Intestinal Diseases, 2018, v. 2, n. 4, p. 236, doi. 10.1159/000491914
- By:
- Publication type:
- Article